Examining issues related to competition in the pharmaceutical marketplace
Subtitle: a review of the FTC report, Generic drug entry prior to patent expiration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, October 9, 2002
Contributors: Muris, Timothy J
Publisher: U.S. G.P.O.; For sale by the Supt. of Docs., U.S. G.P.O. [Congressional Sales Office]
Published: 2002
Place of publication: Washington
Language: eng
Number of pages: 142
Subjects: United States. -- Federal Trade Commission; Generic drugs -- Government policy -- United States; Drugs -- Patents -- United States; Competition -- United States; Pharmaceutical industry -- United States
Genres: Patents
Other titles: Generic drug entry prior to patent expiration
Notes: Distributed to some depository libraries in microfiche

Shipping list no.: 2003-0102-P

"Serial no. 107-140."

Includes bibliographical references